In Vivo Evidence on the Emerging Potential of Non-Digestible Oligosaccharides as Therapeutic Agents in Bacterial and Viral Infections
Nutrients · 2025
DOI: 10.3390/nu17061068 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2025. Verfasst von Amirmohammad Afsharnia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584 CB Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Oligosaccharides, Antiviral Agents, Bacterial Infections, Virus Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, FrieslandCampina.
Abstract (Originalsprache)
The issue of antibiotic-resistant bacterial infections, coupled with the rise in viral pandemics and the slow development of new antibacterial and antiviral treatments, underscores the critical need for novel strategies to mitigate the spread of drug-resistant pathogens, enhance the efficacy of existing therapies, and accelerate the discovery and deployment of innovative antimicrobial and antiviral solutions. One promising approach to address these challenges is the dietary supplementation of non-digestible oligosaccharides (NDOs). NDOs, including human milk oligosaccharides (HMOs), play a vital role in shaping and sustaining a healthy gut microbiota. Beyond stimulating the growth and activity of beneficial gut bacteria, NDOs can also interact directly with pathogenic bacteria and viruses. Their antiviral and antibacterial properties arise from their unique interactions with pathogens and their ability to modulate the host’s immune system. NDOs can function as decoy receptors, inhibit pathogen growth, bind to bacterial toxins, stimulate the host immune response, exhibit anti-biofilm properties, and enhance barrier protection. However, a notable gap exists in the comprehensive assessment of in vivo and clinical data on this topic. This review aims to provide an in-depth overview of the in vivo evidence related to the antiviral and antibacterial effects of various NDOs and HMOs, with a focus on discussing their possible mechanisms of action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584 CB Utrecht, The Netherlands.
- Department of Pharmacology, Jiangsu Provincial Key Laboratory of Critical Care Medicine, School of Medicine, Southeast University, Nanjing 210009, China.
- FrieslandCampina, 3818 LE Amersfoort, The Netherlands.
- Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, The Netherlands.
ORCID-Profile: Yang Cai, Gert Folkerts, Marc M S M Wösten, Saskia Braber
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- FrieslandCampina
- FrieslandCampina, The Netherlands
Zitieren
APA
Afsharnia, A., Cai, Y., Nauta, A., Groeneveld, A., Folkerts, G., Wösten, M. M. S. M., & Braber, S. (2025). In Vivo Evidence on the Emerging Potential of Non-Digestible Oligosaccharides as Therapeutic Agents in Bacterial and Viral Infections. Nutrients. https://doi.org/10.3390/nu17061068
Vancouver
Afsharnia A, Cai Y, Nauta A, Groeneveld A, Folkerts G, Wösten MMSM, et al. In Vivo Evidence on the Emerging Potential of Non-Digestible Oligosaccharides as Therapeutic Agents in Bacterial and Viral Infections. Nutrients. 2025. doi:10.3390/nu17061068
BibTeX
@article{Afsharnia2025,
author = {Afsharnia, Amirmohammad and Cai, Yang and Nauta, Arjen and Groeneveld, Andre and Folkerts, Gert and Wösten, Marc M S M and Braber, Saskia},
title = {In Vivo Evidence on the Emerging Potential of Non-Digestible Oligosaccharides as Therapeutic Agents in Bacterial and Viral Infections},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17061068}
}
EUVIMED